Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
D000328:Adult; D000368:Aged; D001778:Blood Coagulation Disorders / Q000097:blood / Q000628:therapy*; D003131:Combined Modality Therapy; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015539:Platelet Activation / Q000187:drug effects; D017713:Platelet Transfusion; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013917:Thrombin / Q000378:metabolism*; D013921:Thrombocytopenia / Q000097:blood / Q000628:therapy*; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000097:blood / Q000628:therapy
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa; D013917:Thrombin